DiaSorin SpA (DIA):企業の財務・戦略的SWOT分析

◆英語タイトル:DiaSorin SpA (DIA) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDME1679FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:48
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イタリア
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

DiaSorin SpA (DIA) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

DiaSorin SpA (DiaSorin) is a medical diagnostics company that develops, manufactures, and markets in vitro diagnostics reagent kits and systems. The company develops reagent kits based on Enzyme Linked Immunosorbent Assays (ELISA) and Chemiluminescence (CLIA) techniques, to enable automatic diagnostic investigation. The company’s immunodiagnostic and molecular diagnostics products find application in the diagnosis of infectious diseases, bone and mineral disorders, endocrinology, hypertension, oncology, gastrointestinal infections, autoimmune disorders, and neurological and cardiac diseases. DiaSorin markets its products through direct sales force and distributors. It has operations in North America, South America, South Africa, Europe, the Middle East, Africa and Asia. DiaSorin is headquartered in Saluggia, Piemonte, Italy.

DiaSorin SpA Key Recent Developments

Mar 31,2020: AdvaMed: COVID-19 test availability rapidly scales up
Mar 20,2020: Diagnostics Manufacturers ramping up COVID-19 tests to combat pandemic

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
DiaSorin SpA – Key Facts
DiaSorin SpA – Key Employees
DiaSorin SpA – Key Employee Biographies
DiaSorin SpA – Major Products and Services
DiaSorin SpA – History
DiaSorin SpA – Company Statement
DiaSorin SpA – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
DiaSorin SpA – Business Description
Product Category: CLIA Tests
Overview
Performance
Product Category: ELISA Tests
Overview
Performance
Product Category: Instruments Sales and Other Revenue
Performance
Product Category: Molecular Tests
Overview
Performance
Geographical Segment: Asia Pacific
Performance
Geographical Segment: Europe and Africa
Performance
Geographical Segment: Latin America
Performance
Geographical Segment: USA and Canada
Performance
R&D Overview
DiaSorin SpA – Corporate Strategy
DiaSorin SpA – SWOT Analysis
SWOT Analysis – Overview
DiaSorin SpA – Strengths
DiaSorin SpA – Weaknesses
DiaSorin SpA – Opportunities
DiaSorin SpA – Threats
DiaSorin SpA – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
DiaSorin SpA, Medical Equipment, Deals By Year, 2015 to YTD 2021
DiaSorin SpA, Medical Equipment, Deals By Type, 2015 to YTD 2021
DiaSorin SpA, Recent Deals Summary
Section 5 – Company’s Recent Developments
Mar 31, 2020: AdvaMed: COVID-19 test availability rapidly scales up
Mar 20, 2020: Diagnostics Manufacturers ramping up COVID-19 tests to combat pandemic
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
DiaSorin SpA, Key Facts
DiaSorin SpA, Key Employees
DiaSorin SpA, Key Employee Biographies
DiaSorin SpA, Major Products and Services
DiaSorin SpA, History
DiaSorin SpA, Other Locations
DiaSorin SpA, Subsidiaries
DiaSorin SpA, Key Competitors
DiaSorin SpA, Ratios based on current share price
DiaSorin SpA, Annual Ratios
DiaSorin SpA, Annual Ratios (Cont...1)
DiaSorin SpA, Annual Ratios (Cont...2)
DiaSorin SpA, Interim Ratios
DiaSorin SpA, Medical Equipment, Deals By Year, 2015 to YTD 2021
DiaSorin SpA, Medical Equipment, Deals By Type, 2015 to YTD 2021
DiaSorin SpA, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[DiaSorin SpA (DIA):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Protokinetix Inc (PKTX):企業の財務・戦略的SWOT分析
    Summary ProtoKinetix Inc (ProtoKinetix) is a biotechnology company that develops solutions for cell survival and health. The company develops anti-aging glycopeptides used to protect cell lines including hela cells, neonatal fibroblasts, adult fibroblast, human neuronal stem cells, CD34+ cells and k …
  • Transfield Holdings Pty Ltd:企業の戦略的SWOT分析
    Transfield Holdings Pty Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Aruba Networks, Inc.:企業の戦略・SWOT・財務情報
    Aruba Networks, Inc. - Strategy, SWOT and Corporate Finance Report Summary Aruba Networks, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Southwestern Energy Company:企業の戦略・SWOT・財務情報
    Southwestern Energy Company - Strategy, SWOT and Corporate Finance Report Summary Southwestern Energy Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Humabs BioMed SA:製薬・医療:M&Aディール及び事業提携情報
    Summary Humabs BioMed SA (Humabs), a subsidiary of Vir Biotechnology Inc, is an antibody therapeutics biotechnology company that discovers and develops human monoclonal antibodies. The company’s pipeline programs include Flu A virus, ebola virus, HBV, rabies virus, JCV, dengue, and others. It develo …
  • Imaging Dynamics Company Ltd (IDL):医療機器:M&Aディール及び事業提携情報
    Summary Imaging Dynamics Company Ltd (IDC) is a medical device company that offers medical imaging and digital radiography technology solutions. The company provides detector series, proprietary software and DR series products. Its software products include Magellan medical image processing software …
  • Petro Matad Ltd (MATD):企業の財務・戦略的SWOT分析
    Summary Petro Matad Ltd (Petro Matad) is an oil and gas company that develops and operates oil and gas exploration properties. The company’s upstream oil and gas exploration asset base includes Block IV, Block XX, and Block V. Its Block XX is located in the far eastern part of Mongolia producing oil …
  • Agilvax Inc-製薬・医療分野:企業M&A・提携分析
    Summary Agilvax Inc (Agilvax) is a drug company that discovers and develops vaccines against infectious diseases and immunotherapies to treat cancer. The company develops products based on a proprietary virus-like particle platform technology. It develops immunotherapies to treat breast cancer, lung …
  • Crescent Point Energy Corp (CPG):企業の財務・戦略的SWOT分析
    Crescent Point Energy Corp (CPG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Velesto Energy Bhd (UMWOG):石油・ガス:M&Aディール及び事業提携情報
    Summary Velesto Energy Bhd (Velesto) formerly UMW Oil & Gas Corp Bhd, a subsidiary of UMW Holdings Bhd, is an oil and gas company that offers drilling and oilfield services. The company’s services include offshore drilling, hydraulic workover services, threading, inspection and repair services. Its …
  • Central Japan Railway Company:企業の戦略・SWOT・財務分析
    Central Japan Railway Company - Strategy, SWOT and Corporate Finance Report Summary Central Japan Railway Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • NovaBay Pharmaceuticals Inc (NBY):企業の財務・戦略的SWOT分析
    Summary NovaBay Pharmaceuticals Inc (NovaBay), formerly NovaCal Pharmaceuticals Inc is a biopharmaceutical company that discovers and develops eyecare products. The company’s products include skin and wound cleanser, daily lid and lash hygiene spray solutions, and cosetic procedures. Its daily lid a …
  • Medigard Ltd (MGZ):医療機器:M&Aディール及び事業提携情報
    Summary Medigard Ltd (Medigard), formerly Medisafe Instruments Pty Ltd, is a medical device company that designs and develops retractable safety medical devices. The company provides products such as auto-retractable syringe, manual retractable syringe, blood collection device, intravenous valve and …
  • GenMark Diagnostics Inc (GNMK):企業の財務・戦略的SWOT分析
    Summary GenMark Diagnostics Inc (GenMark) is a medical device company that provides clinical testing systems. The company offers products such as XT-8 systems and ePlex systems. It offers pipeline products include eSensor 2C 19 genotyping test, eSensor HCV genotyping test, eSensor HCVg direct test, …
  • United States Cellular Corp (USM):企業の財務・戦略的SWOT分析
    United States Cellular Corp (USM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Credit Agricole CIB SA:企業の戦略的SWOT分析
    Credit Agricole CIB SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Denver Water:企業の戦略的SWOT分析
    Denver Water - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Texas A&M University:製薬・医療:M&Aディール及び事業提携情報
    Summary Texas A&M University (TAMU) is a research based university that provide educational and research services. The university offers undergraduate, graduate and professional courses to its students. It consists of various colleges and departments such as College of Agriculture and Life Sciences, …
  • Kaken Pharmaceutical Co Ltd (4521):製薬・医療:M&Aディール及び事業提携情報
    Summary Kaken Pharmaceutical Co Ltd (Kaken Pharma) is a pharmaceutical company that conducts research and develops drugs, agrochemicals, medical equipment and animal health products. The company offers solutions in the fields of orthopedics, dermatology, immunology, inflammation, allergies, fungal i …
  • The Empire District Electric Co:企業の戦略的SWOT分析
    The Empire District Electric Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆